Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada.

Metcalfe M, Kassouf W, Rendon R, Bell D, Izawa J, Chin J, Kapoor A, Matsumoto E, Lattouf JB, Saad F, Lacombe L, Fradet Y, Fairey A, Jacobson NE, Drachenberg D, Cagiannos I, So A, Black P.

Can Urol Assoc J. 2012 Dec;6(6):455-62. doi: 10.5489/cuaj.12146.

PMID:
23282664
[PubMed]
Free PMC Article
2.

Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration.

Fairey AS, Kassouf W, Estey E, Tanguay S, Rendon R, Bell D, Izawa J, Chin J, Kapoor A, Matsumoto E, Black P, So A, Lattouf JB, Saad F, Drachenberg D, Cagiannos I, Lacombe L, Fradet Y, Jacobsen NE.

BJU Int. 2013 Oct;112(6):791-7. doi: 10.1111/j.1464-410X.2012.11474.x. Epub 2012 Nov 13.

PMID:
23148712
[PubMed - indexed for MEDLINE]
3.

Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.

Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W.

BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16.

PMID:
22177329
[PubMed - indexed for MEDLINE]
4.

Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.

Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA.

BJU Int. 2012 Sep;110(5):614-28. doi: 10.1111/j.1464-410X.2012.11068.x. Epub 2012 Apr 3. Review.

PMID:
22471401
[PubMed - indexed for MEDLINE]
5.

The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrence.

Kapoor A, Dason S, Allard CB, Shayegan B, Lacombe L, Rendon R, Jacobsen NE, Fairey A, Izawa J, Black P, Tanguay S, Chin J, So A, Lattouf JB, Bell D, Saad F, Drachenberg D, Cagiannos I, Fradet Y, Alamri A, Kassouf W.

Can Urol Assoc J. 2014 Nov;8(11-12):E845-52. doi: 10.5489/cuaj.1985.

PMID:
25485014
[PubMed]
Free PMC Article
6.

No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study.

Burger M, Shariat SF, Fritsche HM, Martinez-Salamanca JI, Matsumoto K, Chromecki TF, Ficarra V, Kassouf W, Seitz C, Pycha A, Tritschler S, Walton TJ, Novara G.

World J Urol. 2011 Aug;29(4):465-72. doi: 10.1007/s00345-011-0705-0. Epub 2011 Jun 1.

PMID:
21630120
[PubMed - indexed for MEDLINE]
7.

Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma.

Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G.

World J Urol. 2011 Aug;29(4):481-6. doi: 10.1007/s00345-010-0594-7. Epub 2010 Oct 1.

PMID:
20886219
[PubMed - indexed for MEDLINE]
8.

The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience.

Mason RJ, Kassouf W, Bell DG, Lacombe L, Kapoor A, Jacobsen N, Fairey A, Izawa J, Black P, Tanguay S, Chin J, So A, Lattouf JB, Saad F, Matsumoto E, Drachenberg D, Cagiannos I, Fradet Y, Rendon RA.

Urology. 2012 Apr;79(4):840-5. doi: 10.1016/j.urology.2011.11.058. Epub 2012 Feb 25.

PMID:
22365453
[PubMed - indexed for MEDLINE]
9.

Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.

Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF.

BJU Int. 2011 Aug;108(3):406-12. doi: 10.1111/j.1464-410X.2010.09826.x. Epub 2010 Nov 15.

PMID:
21078048
[PubMed - indexed for MEDLINE]
10.

Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients.

Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G.

World J Urol. 2011 Aug;29(4):487-94. doi: 10.1007/s00345-011-0645-8. Epub 2011 Jan 20.

PMID:
21249372
[PubMed - indexed for MEDLINE]
11.

Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies.

Ni S, Tao W, Chen Q, Liu L, Jiang H, Hu H, Han R, Wang C.

Eur Urol. 2012 Jun;61(6):1142-53. doi: 10.1016/j.eururo.2012.02.019. Epub 2012 Feb 15. Review.

PMID:
22349569
[PubMed - indexed for MEDLINE]
12.

Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.

Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, Ng C, Kikuchi E, Zigeuner R, Kassouf W, Fritsche HM, Ficarra V, Martignoni G, Tritschler S, Rodriguez JC, Seitz C, Weizer A, Remzi M, Raman JD, Bolenz C, Bensalah K, Koppie TM, Karakiewicz PI, Wood CG, Montorsi F, Iwamura M, Shariat SF.

BJU Int. 2011 Oct;108(8 Pt 2):E304-9. doi: 10.1111/j.1464-410X.2011.10188.x. Epub 2011 Apr 20.

PMID:
21507184
[PubMed - indexed for MEDLINE]
13.

Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.

Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V.

Eur Urol. 2012 Apr;61(4):818-25. doi: 10.1016/j.eururo.2012.01.021. Epub 2012 Jan 23.

PMID:
22284969
[PubMed - indexed for MEDLINE]
14.

Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.

Godfrey MS, Badalato GM, Hruby GW, Razmjoo M, McKiernan JM.

BJU Int. 2012 Sep;110(6):798-803. doi: 10.1111/j.1464-410X.2011.10893.x. Epub 2012 Feb 7.

PMID:
22313599
[PubMed - indexed for MEDLINE]
15.

Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.

Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG; Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma Collaboration.

Cancer. 2009 Mar 15;115(6):1224-33. doi: 10.1002/cncr.24135.

PMID:
19156917
[PubMed - indexed for MEDLINE]
Free Article
16.

Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.

Fernández MI, Shariat SF, Margulis V, Bolenz C, Montorsi F, Suardi N, Remzi M, Wood CG, Roscigno M, Kikuchi E, Oya M, Zigeuner R, Langner C, Weizer A, Lotan Y, Koppie TM, Raman JD, Karakiewicz P, Bensalah K, Schultz M, Bernier P.

Urology. 2009 Jan;73(1):142-6. doi: 10.1016/j.urology.2008.07.042. Epub 2008 Oct 8. Erratum in: Urology. 2010 May;75(5):1243. Karakiewizc, Pierre [corrected to Karakiewicz, Pierre].

PMID:
18845322
[PubMed - indexed for MEDLINE]
17.

Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Langner C, Lotan Y, Weizer A, Bensalah K, Raman JD, Bolenz C, Guo CC, Wood CG, Zigeuner R, Wheat J, Kabbani W, Koppie TM, Ng CK, Suardi N, Bertini R, Fernández MI, Mikami S, Isida M, Michel MS, Montorsi F.

J Urol. 2009 Jun;181(6):2482-9. doi: 10.1016/j.juro.2009.02.021. Epub 2009 Apr 16.

PMID:
19371878
[PubMed - indexed for MEDLINE]
18.

Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.

Rink M, Ehdaie B, Cha EK, Green DA, Karakiewicz PI, Babjuk M, Margulis V, Raman JD, Svatek RS, Fajkovic H, Lee RK, Novara G, Hansen J, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Fisch M, Scherr DS, Shariat SF; Bladder Cancer Research Consortium (BCRC); Upper Tract Urothelial Carcinoma Collaboration (UTUCC).

Eur Urol. 2012 Oct;62(4):677-84. Epub 2012 Feb 15.

PMID:
22349570
[PubMed - indexed for MEDLINE]
19.

The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.

Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, Lotan Y, Raman JD, Kassouf W, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Walton TJ, Pycha A, Ficarra V, Karakiewicz PI, Zigeuner R, Pummer K, Shariat SF.

Eur Urol. 2012 Feb;61(2):245-53. doi: 10.1016/j.eururo.2011.09.017. Epub 2011 Sep 28.

PMID:
21975249
[PubMed - indexed for MEDLINE]
20.

Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.

Wheat JC, Weizer AZ, Wolf JS Jr, Lotan Y, Remzi M, Margulis V, Wood CG, Montorsi F, Roscigno M, Kikuchi E, Zigeuner R, Langner C, Bolenz C, Koppie TM, Raman JD, Fernández M, Karakiewizc P, Capitanio U, Bensalah K, Patard JJ, Shariat SF.

Urol Oncol. 2012 May-Jun;30(3):252-8. doi: 10.1016/j.urolonc.2010.01.001. Epub 2010 May 6.

PMID:
20451416
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk